financetom
Business
financetom
/
Business
/
Top News Podcast: SEC nod to Covaxin for kids aged 2-18; no cap on domestic flight capacity from Oct 18; Gmail outage and more
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top News Podcast: SEC nod to Covaxin for kids aged 2-18; no cap on domestic flight capacity from Oct 18; Gmail outage and more
Oct 12, 2021 10:04 AM

An expert panel of India's central drug authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children and adolescents in the 2 to 18 years age group.

Meanwhile, the Ministry of Civil Aviation on Tuesday announced that airlines can operate domestic flights without any capacity restriction from October 18 onwards.

In this edition of Top News Podcast, CNBCTV18.com’s Kanishka Sarkar shares more updates on the country’s energy crisis, Gmail outage in several regions and more on the economy, politics, and health.

Tune in to Top News Podcast for more

In case you have any queries or suggestions, please write to us on [email protected].

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Argentina's YPF swings to Q3 net loss on tax expenses
Argentina's YPF swings to Q3 net loss on tax expenses
Nov 7, 2025
BUENOS AIRES, Nov 7 (Reuters) - Argentina's state-controlled energy company YPF swung to a net loss of $198 million in the third quarter , the company said on Friday, crediting the loss to a sharp increase in YPF's income tax expense, specifically a deferred tax charge. The company's adjusted earnings before interest, tax, depreciation and amortization (EBITDA), a key measure...
Alphabet Insider Sold Shares Worth $9,212,980, According to a Recent SEC Filing
Alphabet Insider Sold Shares Worth $9,212,980, According to a Recent SEC Filing
Nov 7, 2025
05:20 PM EST, 11/07/2025 (MT Newswires) -- Sundar Pichai, Director, Chief Executive Officer, on November 05, 2025, sold 32,500 shares in Alphabet (GOOGL) for $9,212,980. Following the Form 4 filing with the SEC, Pichai has control over a total of 2,337,119 Class C capital shares, 227,560 Class A common shares and 74,874 Class C Google stock units, all held directly....
Ionis Pharmaceuticals Insider Sold Shares Worth $609,379, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $609,379, According to a Recent SEC Filing
Nov 7, 2025
05:21 PM EST, 11/07/2025 (MT Newswires) -- Brian Birchler, Executive Vice President, Corporate and Development Operations, on November 06, 2025, sold 8,000 shares in Ionis Pharmaceuticals ( IONS ) for $609,379. Following the Form 4 filing with the SEC, Birchler has control over a total of 48,826 common shares of the company, with 48,826 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874015/000087401525000278/xslF345X05/edgardoc.xml...
Ionis Pharmaceuticals Insider Sold Shares Worth $2,621,816, According to a Recent SEC Filing
Ionis Pharmaceuticals Insider Sold Shares Worth $2,621,816, According to a Recent SEC Filing
Nov 7, 2025
05:21 PM EST, 11/07/2025 (MT Newswires) -- Richard S Geary, Executive Vice President, Chief Development Officer, on November 05, 2025, sold 34,639 shares in Ionis Pharmaceuticals ( IONS ) for $2,621,816. Following the Form 4 filing with the SEC, Geary has control over a total of 59,657 common shares of the company, with 59,657 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/874015/000087401525000277/xslF345X05/edgardoc.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved